Labopharm Inc. (Nasdaq: DDSS) shares are up nearly 4 percent on volume of about 12,000 shares in premarket trading around 8:15 a.m. Eastern. There is nothing new that we’ve found on the stock this morning. But relative volume has increased more than two-fold over its monthly average this week. The consort expects to hear from the FDA in coming weeks if its Trazodone OD once-daily depression drug will be authorised in the U.S. — Mike Tarsala
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment